Abstract
Objectives
To evaluate the spectrum of PTPN11 gene mutations in Noonan syndrome patients and to study the genotype–phenotype associations.
Methods
In this study, twenty Noonan syndrome patients with PTPN11 mutations were included. The patients underwent a detailed clinical and physical evaluation. To identify inherited cases, parents of all mutation positive patients were analyzed.
Results
Thirteen different PTPN11 mutations, two of them being novel, were detected in the study group. These mutations included eleven missense mutations: p.G60A, p.D61N, p.Y62D, p.Y63C, p.E69Q, p.Q79R, p.Y279C,p.N308D, p.N308S, p.M504V, p.Q510R and two novel missense mutations: p.I56V and p.I282M. The frequency of cardiac abnormalities and short stature were found to be 80 % and 80 %, respectively. Mental retardation was not observed in patients having exon 8 mutations. No significant correlations were detected between other phenotypic features and genotypes.
Conclusions
By identifying genotype-phenotype correlations, this study provides information on phenotypes observed in NS patients with different PTPN11 mutations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papadopoulou A, Issakidis M, Gole E, et al. Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment. Eur J Pediatr. 2012;171:51–8.
Jongmans M, Sistermans EA, Rikken A, et al. Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. Am J Med Genet A. 2005;134A:165–70.
Jorge AA, Malaquias AC, Arnhold IJ, Mendonca BB. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway. Horm Res. 2009;71:185–93.
Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet. 1985;21:493–506.
Romano AA, Allanson JE, Dahlgren J, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010;126:746–59.
Duncan WJ, Fowler RS, Farkas LG, et al. A comprehensive scoring system for evaluating Noonan syndrome. Am J Med Genet. 1981;10:37–50.
Neri G, Allanson J, Kavamura MI. No reason yet to change diagnostic criteria for Noonan Costello and cardio-facio-cutaneous syndromes. J Med Genet. 2008;45:832.
van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994;53:187–91.
Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–8.
Essawi ML, Ismail MF, Afifi HH, Kobesiy MM, El Kotoury A, Barakat MM. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome. J Formos Med Assoc. 2013;112:707–12.
van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007;2:4.
Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70:1555–63.
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. Mutation taster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–6.
Simsek-Kiper PO, Alanay Y, Gulhan B, et al. Clinical and molecular analysis of RASopathies in a group of Turkish patients. Clin Genet. 2013;83:181–6.
Tartaglia M, Cordeddu V, Chang H, et al. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am J Hum Genet. 2004;75:492–7.
Musante L, Kehl HG, Majewski F, et al. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet. 2003;11:201–6.
Bertola DR, Pereira AC, Albano LM, De Oliveira PS, Kim CA, Krieger JE. PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype. Genet Test. 2006;10:186–91.
Zenker M, Buheitel G, Rauch R, et al. Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004;144:368–74.
Jongmans M, Otten B, Noordam K, van der Burgt I. Genetics and variation in phenotype in Noonan syndrome. Horm Res. 2004;62:56–9.
Acknowledgments
The authors would like to thank the children with Noonan syndrome and parents who participated in the study and shared their information.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Contributions
TA, FH and FO: Designed and wrote the study; TA, AA and HO: Evaluated and interpreted sequencing results; DG, SD, AT and FO: Provided guidance with respect to the clinical perspective of the study. FO will act as guarantor for the paper.
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Atik, T., Aykut, A., Hazan, F. et al. Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations. Indian J Pediatr 83, 517–521 (2016). https://doi.org/10.1007/s12098-015-1998-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-015-1998-6